Skip to main content
logo
Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
941.60
-10.35 (-1.09%)
Sep 11, 2025, 3:29 PM IST

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 17.11B INR in the quarter ending June 30, 2025, with 9.54% growth. This brings the company's revenue in the last twelve months to 68.21B, up 8.20% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

Revenue (ttm)
68.21B
Revenue Growth
+8.20%
P/S Ratio
2.73
Revenue / Employee
4.12M
Employees
16,571
Market Cap
186.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Alkem Laboratories133.04B
Revenue Rankings

Alembic Pharmaceuticals News

More News